Amgen Inc (AMGN)
263.38
+2.19
(+0.84%)
USD |
NASDAQ |
Dec 20, 16:00
262.99
-0.39
(-0.15%)
After-Hours: 20:00
Amgen Free Cash Flow: 6.283B for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -2.275B |
| Merck & Co Inc | 14.84B |
| Pfizer Inc | 8.227B |
| Regeneron Pharmaceuticals Inc | 3.319B |
| Viking Therapeutics Inc | -74.25M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.571B |
| Cash from Investing (Quarterly) | -210.00M |
| Cash from Financing (Quarterly) | -3.651B |
| Free Cash Flow Per Share (Quarterly) | 6.114 |
| Free Cash Flow to Equity (Quarterly) | 5.561B |
| Free Cash Flow to Firm (Quarterly) | 4.022B |
| Free Cash Flow Yield | 4.42% |